×

GILEAD SCIENCES SETS PRICE FOR YESCARTA, CAR-T LYMPHOMA DRUG APPROVED BY FDA AT $373,000

GILEAD SCIENCES SETS PRICE FOR YESCARTA, CAR-T LYMPHOMA DRUG APPROVED